Scientists at USC Michelson Center for Convergent Bioscience and Japan’s Nagoya University find and test a promising drug that stops cancer by interfering with the cancer cells’ metabolism and other circadian-related functions
A new drug shows potential to halt cancer cells’ growth by stunting the cells’ biological clock.
The findings from scientists at the USC Michelson Center for Convergent Bioscience and Nagoya University’s Institute of Transformative BioMolecules (ITbM) advance a burgeoning area of research: turning the body’s circadian rhythms against cancer.
Their study, conducted on human kidney cancer cells and on acute myeloid leukemia in mice, was published Jan. 23 in the journal Science Advances.
Scientists know that disrupting sleep and other elements of humans’ circadian rhythm can harm health. The same is true for the circadian clock of cells themselves. If researchers could disturb the circadian clock of cancer cells, they theorize, they could potentially hurt or kill those cells.
The scientists found that a molecule named GO289 targets an enzyme that controls the cell’s circadian rhythm. This drug-protein interaction then disrupts the functions of four other proteins that are important for cell growth and survival.
Human bone cancer cells stopped growing when a drug molecule jammed their circadian rhythm during a study that appears in Science Advances. Photo courtesy of the Kay lab at the USC Michelson Center for Convergent Bioscience.
In effect, GO289 can jam the cogs of the cell’s circadian clock, slowing its cycles. And it can do so with little impact to healthy cells.
“In some cancers, the disease takes over the circadian clock mechanism and uses it for the evil purpose of helping itself grow,” said Steve Kay, director of convergent biosciences at the USC Michelson Center and USC Provost Professor of Neurology, Biomedical Engineering and Biological Sciences. “With GO289, we can interfere with those processes and stop the cancer from growing.”
Kay is among several scientists from USC Dornsife College of Letters, Arts and Sciences, USC Viterbi School of Engineering and Keck School of Medicine of USC who are collaborating across multiple disciplines to find new solutions for treating cancer, neurological disease and cardiovascular disease.
Finding the right candidate
On its initial interactions with human bone cancer cells, GO289 appeared to slow the tumors’ circadian clock as it targeted an enzyme, named CK2.
To see if GO289 consistently hindered other cancers in the same way, the scientists then tested it on human kidney cancer cells and on mice with acute myeloid leukemia. They found that GO289 specifically affected cancer cell metabolism and other circadian-related functions that normally would enable the cancer to grow and spread.
Kay is optimistic about the findings. “This could become an effective new weapon that kills cancer,” he said.
The Latest on: Cancer
via Google News
The Latest on: Cancer
- Season of Sharing helps Marin County artist recover after canceron November 29, 2020 at 4:00 am
It’s been a long road to recovery for the Marin County artist, and with the help of others, including the donors at The Chronicle Fund, she hasn’t felt entirely alone through it all. “I’m supposed to ...
- Bowel cancer symptoms: Polyps can develop into the deadly disease - what are they?on November 29, 2020 at 2:25 am
BOWEL cancer is the second biggest cancer killer in the UK; the deadly disease predominately affects people over the age of 50. However, early detection can lead to successful treatment and cure.
- Louisiana’s lung cancer survival rate suggests it may often go undetectedon November 28, 2020 at 3:30 pm
Louisiana residents who get lung cancer are more likely to die from it than people in almost any other state, a statistic researchers say might have as much to do with Louisiana's dismal record for ...
- Housewives a high-risk group, account for 78.5% of cancer cases among Chandigarh womenon November 28, 2020 at 10:41 am
Bad food habits, stress and lack of exercise to be blamed, say experts; among men, govt employees were the most likely to develop the disease ...
- 'Turncoat' macrophages in the tumor 'micro-environment' underlie breast cancer progressionon November 27, 2020 at 11:31 am
New research that is examining the "tumor microenvironment" reveals not only how macrophages can become extraordinary turncoats but also how they can actively support tumor growth and metastatic ...
- Frozen Eggs Help Breast Cancer Survivors Conceiveon November 27, 2020 at 7:18 am
Freezing their eggs or ovarian tissue before breast cancer treatment increases survivors' chances of having children after recovery, a new study finds. Nearly 10% of breast cancer cases occur in women ...
- Blood Test That Detects 50 Types of Cancer To Be Testedon November 27, 2020 at 5:32 am
Researchers hope the Galleri blood test will be a "gamechanger" for early cancer diagnosis, potentially saving many lives.
- NHS to trial blood test to detect more than 50 forms of canceron November 26, 2020 at 8:37 pm
Researchers hopes Galleri trial will be a ‘gamechanger’ for early diagnosis and save many lives ...
- Cancer: Blood test for 50 types to be trialled by NHSon November 26, 2020 at 4:23 pm
A blood test designed to detect more than 50 types of cancer at an early stage will be trialled by the NHS. More than 165,000 people in England will be offered the tests from next year. If successful, ...
- Big data powers design of 'smart' cell therapies for canceron November 26, 2020 at 11:02 am
Finding medicines that can kill cancer cells while leaving normal tissue unscathed is a Holy Grail of oncology research. In two new papers, scientists at UC San Francisco and Princeton University ...
via Bing News